In 2018 an investigation by the International Consortium of Investigative Journalists revealed that 83,000 deaths and over ...

Recursion Pharmaceuticals is reshaping drug discovery with AI, strategic partnerships, and financial discipline for long-term ...

Efficiency and cost-effectiveness are key drivers in these recent developments in AI drug discovery ... to translational research with the goal of accelerating the development of therapeutics ...

Overall, DoE is a valuable approach to improving the quality and efficacy of the final product, streamlining the process, and ...

The research ecosystem needs to incentivise companies ... in scientific understanding and the clinical and commercial development of new treatments. Academic researchers have historically been able to ...

Charles River Labs has a strong history in supporting neuroscience and neurodegenerative diseases across all stages of drug ...

Exosome Binding Protein (EBP) can be used to direct other proteins to exosomes, effectively allowing for targeted delivery of ...

The discovery of new biomarkers, drug targets, and therapeutic mechanisms is pivotal for the development of effective treatments across a spectrum of diseases. Traditional methods, such as omics ...

The development of molecules to study and treat disease is becoming increasingly burdened by the time and specificity required to analyze the vast amounts of data generated by synthesizing large ...

The 2nd Covalent Drug Discovery and Development Summit returns as the central hub dedicated to every aspect of covalency from discovery to translation and clinical development, equipping 100+ global ...

As these goals materialize, reducing the high cost of drug discovery and development through the ... transforms drug discovery—accelerating research, reducing costs, and enabling breakthroughs ...

General Inception, a global biotech company igniter, and Enable Medicine, a leader in AI-led data analysis for biological research and drug discovery, today announce an equity and strategic ...